Global Softgel CDMO Market Insights, Forecast to 2030

Industry: Service & Software

Published: 2024-04-25

Pages: 108 Pages

Report ld: 2960672

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Market Analysis and Insights: Global Softgel CDMO Market
The global Softgel CDMO market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Softgel CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Softgel CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Softgel CDMO is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Softgel CDMO include Catalent, Aenova, Sirio Pharma, Procaps, Patheon, NextPharma, Lonza, Samsung Biologics and Fareva, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Softgel CDMO is widely used in various fields, such as Pharmaceutical Company, Biotechnology Company and Others,, etc. Pharmaceutical Company provides greatest supports to the Softgel CDMO industry development. In 2023, global % revenue of Softgel CDMO went into Pharmaceutical Company filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Softgel CDMO market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Softgel CDMO, also provides the revenue of main regions and countries. of the upcoming market potential for Softgel CDMO, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Softgel CDMO revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Softgel CDMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Softgel CDMO revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Catalent, Aenova, Sirio Pharma, Procaps, Patheon, NextPharma, Lonza, Samsung Biologics and Fareva, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Softgel CDMO Market Insights, Forecast to 2030
Market Size Available for Years
2024-2030
Global Softgel CDMO Companies Covered
Catalent
Aenova
Sirio Pharma
Procaps
Patheon
NextPharma
Lonza
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
Global Softgel CDMO Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Softgel CDMO Market, Segment by Type
Pharmaceutical Softgel CDMO
Nutraceutical Softgel CDMO
Others
Global Softgel CDMO Market, Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Softgel CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Softgel CDMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Softgel CDMO revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Softgel CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Pharmaceutical Softgel CDMO
        1.2.3 Nutraceutical Softgel CDMO
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Softgel CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Pharmaceutical Company
        1.3.3 Biotechnology Company
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Softgel CDMO Market Perspective (2019-2030)
    2.2 Global Softgel CDMO Growth Trends by Region
        2.2.1 Softgel CDMO Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Softgel CDMO Historic Market Size by Region (2019-2024)
        2.2.3 Softgel CDMO Forecasted Market Size by Region (2025-2030)
    2.3 Softgel CDMO Market Dynamics
        2.3.1 Softgel CDMO Industry Trends
        2.3.2 Softgel CDMO Market Drivers
        2.3.3 Softgel CDMO Market Challenges
        2.3.4 Softgel CDMO Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Softgel CDMO by Players
        3.1.1 Global Softgel CDMO Revenue by Players (2019-2024)
        3.1.2 Global Softgel CDMO Revenue Market Share by Players (2019-2024)
    3.2 Global Softgel CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Softgel CDMO, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Softgel CDMO Market Concentration Ratio
        3.4.1 Global Softgel CDMO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Softgel CDMO Revenue in 2023
    3.5 Global Key Players of Softgel CDMO Head office and Area Served
    3.6 Global Key Players of Softgel CDMO, Product and Application
    3.7 Global Key Players of Softgel CDMO, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Softgel CDMO Breakdown Data by Type
    4.1 Global Softgel CDMO Historic Market Size by Type (2019-2024)
    4.2 Global Softgel CDMO Forecasted Market Size by Type (2025-2030)

5 Softgel CDMO Breakdown Data by Application
    5.1 Global Softgel CDMO Historic Market Size by Application (2019-2024)
    5.2 Global Softgel CDMO Forecasted Market Size by Application (2025-2030)

6 North America
    6.1 North America Softgel CDMO Market Size (2019-2030)
    6.2 North America Softgel CDMO Market Size by Type
        6.2.1 North America Softgel CDMO Market Size by Type (2019-2024)
        6.2.2 North America Softgel CDMO Market Size by Type (2025-2030)
        6.2.3 North America Softgel CDMO Market Share by Type (2019-2030)
    6.3 North America Softgel CDMO Market Size by Application
        6.3.1 North America Softgel CDMO Market Size by Application (2019-2024)
        6.3.2 North America Softgel CDMO Market Size by Application (2025-2030)
        6.3.3 North America Softgel CDMO Market Share by Application (2019-2030)
    6.4 North America Softgel CDMO Market Size by Country
        6.4.1 North America Softgel CDMO Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Softgel CDMO Market Size by Country (2019-2024)
        6.4.3 North America Softgel CDMO Market Size by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

7 Europe
    7.1 Europe Softgel CDMO Market Size (2019-2030)
    7.2 Europe Softgel CDMO Market Size by Type
        7.2.1 Europe Softgel CDMO Market Size by Type (2019-2024)
        7.2.2 Europe Softgel CDMO Market Size by Type (2025-2030)
        7.2.3 Europe Softgel CDMO Market Share by Type (2019-2030)
    7.3 Europe Softgel CDMO Market Size by Application
        7.3.1 Europe Softgel CDMO Market Size by Application (2019-2024)
        7.3.2 Europe Softgel CDMO Market Size by Application (2025-2030)
        7.3.3 Europe Softgel CDMO Market Share by Application (2019-2030)
    7.4 Europe Softgel CDMO Market Size by Country
        7.4.1 Europe Softgel CDMO Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Softgel CDMO Market Size by Country (2019-2024)
        7.4.3 Europe Softgel CDMO Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Softgel CDMO Market Size (2019-2030)
    8.2 China Softgel CDMO Market Size by Type
        8.2.1 China Softgel CDMO Market Size by Type (2019-2024)
        8.2.2 China Softgel CDMO Market Size by Type (2025-2030)
        8.2.3 China Softgel CDMO Market Share by Type (2019-2030)
    8.3 China Softgel CDMO Market Size by Application
        8.3.1 China Softgel CDMO Market Size by Application (2019-2024)
        8.3.2 China Softgel CDMO Market Size by Application (2025-2030)
        8.3.3 China Softgel CDMO Market Share by Application (2019-2030)

9 Asia (excluding China)
    9.1 Asia Softgel CDMO Market Size (2019-2030)
    9.2 Asia Softgel CDMO Market Size by Type
        9.2.1 Asia Softgel CDMO Market Size by Type (2019-2024)
        9.2.2 Asia Softgel CDMO Market Size by Type (2025-2030)
        9.2.3 Asia Softgel CDMO Market Share by Type (2019-2030)
    9.3 Asia Softgel CDMO Market Size by Application
        9.3.1 Asia Softgel CDMO Market Size by Application (2019-2024)
        9.3.2 Asia Softgel CDMO Market Size by Application (2025-2030)
        9.3.3 Asia Softgel CDMO Market Share by Application (2019-2030)
    9.4 Asia Softgel CDMO Market Size by Region
        9.4.1 Asia Softgel CDMO Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Softgel CDMO Market Size by Region (2019-2024)
        9.4.3 Asia Softgel CDMO Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Softgel CDMO Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Softgel CDMO Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Softgel CDMO Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Softgel CDMO Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Softgel CDMO Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Softgel CDMO Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Softgel CDMO Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Softgel CDMO Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Softgel CDMO Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Softgel CDMO Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Softgel CDMO Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Softgel CDMO Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Softgel CDMO Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
    11.1 Catalent
        11.1.1 Catalent Company Details
        11.1.2 Catalent Business Overview
        11.1.3 Catalent Softgel CDMO Introduction
        11.1.4 Catalent Revenue in Softgel CDMO Business (2019-2024)
        11.1.5 Catalent Recent Developments
    11.2 Aenova
        11.2.1 Aenova Company Details
        11.2.2 Aenova Business Overview
        11.2.3 Aenova Softgel CDMO Introduction
        11.2.4 Aenova Revenue in Softgel CDMO Business (2019-2024)
        11.2.5 Aenova Recent Developments
    11.3 Sirio Pharma
        11.3.1 Sirio Pharma Company Details
        11.3.2 Sirio Pharma Business Overview
        11.3.3 Sirio Pharma Softgel CDMO Introduction
        11.3.4 Sirio Pharma Revenue in Softgel CDMO Business (2019-2024)
        11.3.5 Sirio Pharma Recent Developments
    11.4 Procaps
        11.4.1 Procaps Company Details
        11.4.2 Procaps Business Overview
        11.4.3 Procaps Softgel CDMO Introduction
        11.4.4 Procaps Revenue in Softgel CDMO Business (2019-2024)
        11.4.5 Procaps Recent Developments
    11.5 Patheon
        11.5.1 Patheon Company Details
        11.5.2 Patheon Business Overview
        11.5.3 Patheon Softgel CDMO Introduction
        11.5.4 Patheon Revenue in Softgel CDMO Business (2019-2024)
        11.5.5 Patheon Recent Developments
    11.6 NextPharma
        11.6.1 NextPharma Company Details
        11.6.2 NextPharma Business Overview
        11.6.3 NextPharma Softgel CDMO Introduction
        11.6.4 NextPharma Revenue in Softgel CDMO Business (2019-2024)
        11.6.5 NextPharma Recent Developments
    11.7 Lonza
        11.7.1 Lonza Company Details
        11.7.2 Lonza Business Overview
        11.7.3 Lonza Softgel CDMO Introduction
        11.7.4 Lonza Revenue in Softgel CDMO Business (2019-2024)
        11.7.5 Lonza Recent Developments
    11.8 Samsung Biologics
        11.8.1 Samsung Biologics Company Details
        11.8.2 Samsung Biologics Business Overview
        11.8.3 Samsung Biologics Softgel CDMO Introduction
        11.8.4 Samsung Biologics Revenue in Softgel CDMO Business (2019-2024)
        11.8.5 Samsung Biologics Recent Developments
    11.9 Fareva
        11.9.1 Fareva Company Details
        11.9.2 Fareva Business Overview
        11.9.3 Fareva Softgel CDMO Introduction
        11.9.4 Fareva Revenue in Softgel CDMO Business (2019-2024)
        11.9.5 Fareva Recent Developments
    11.10 WuXi AppTech
        11.10.1 WuXi AppTech Company Details
        11.10.2 WuXi AppTech Business Overview
        11.10.3 WuXi AppTech Softgel CDMO Introduction
        11.10.4 WuXi AppTech Revenue in Softgel CDMO Business (2019-2024)
        11.10.5 WuXi AppTech Recent Developments
    11.11 WuXi Biologics
        11.11.1 WuXi Biologics Company Details
        11.11.2 WuXi Biologics Business Overview
        11.11.3 WuXi Biologics Softgel CDMO Introduction
        11.11.4 WuXi Biologics Revenue in Softgel CDMO Business (2019-2024)
        11.11.5 WuXi Biologics Recent Developments
    11.12 Siegfried
        11.12.1 Siegfried Company Details
        11.12.2 Siegfried Business Overview
        11.12.3 Siegfried Softgel CDMO Introduction
        11.12.4 Siegfried Revenue in Softgel CDMO Business (2019-2024)
        11.12.5 Siegfried Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Softgel CDMO Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Pharmaceutical Softgel CDMO
    Table 3. Key Players of Nutraceutical Softgel CDMO
    Table 4. Key Players of Others
    Table 5. Global Softgel CDMO Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Softgel CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Softgel CDMO Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Softgel CDMO Market Share by Region (2019-2024)
    Table 9. Global Softgel CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Softgel CDMO Market Share by Region (2025-2030)
    Table 11. Softgel CDMO Market Trends
    Table 12. Softgel CDMO Market Drivers
    Table 13. Softgel CDMO Market Challenges
    Table 14. Softgel CDMO Market Restraints
    Table 15. Global Softgel CDMO Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Softgel CDMO Revenue Share by Players (2019-2024)
    Table 17. Global Top Softgel CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Softgel CDMO as of 2023)
    Table 18. Global Softgel CDMO Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Softgel CDMO Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Softgel CDMO, Headquarters and Area Served
    Table 21. Global Key Players of Softgel CDMO, Product and Application
    Table 22. Global Key Players of Softgel CDMO, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Softgel CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Softgel CDMO Revenue Market Share by Type (2019-2024)
    Table 26. Global Softgel CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Softgel CDMO Revenue Market Share by Type (2025-2030)
    Table 28. Global Softgel CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Softgel CDMO Revenue Share by Application (2019-2024)
    Table 30. Global Softgel CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Softgel CDMO Revenue Share by Application (2025-2030)
    Table 32. North America Softgel CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Softgel CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Softgel CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Softgel CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Softgel CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Softgel CDMO Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Softgel CDMO Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Softgel CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Softgel CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Softgel CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Softgel CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Softgel CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Softgel CDMO Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Softgel CDMO Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Softgel CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Softgel CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Softgel CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Softgel CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Softgel CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Softgel CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Softgel CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Softgel CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Softgel CDMO Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Softgel CDMO Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Softgel CDMO Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Softgel CDMO Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Softgel CDMO Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Softgel CDMO Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Softgel CDMO Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Softgel CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Softgel CDMO Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Softgel CDMO Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Catalent Company Details
    Table 65. Catalent Business Overview
    Table 66. Catalent Softgel CDMO Product
    Table 67. Catalent Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 68. Catalent Recent Developments
    Table 69. Aenova Company Details
    Table 70. Aenova Business Overview
    Table 71. Aenova Softgel CDMO Product
    Table 72. Aenova Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 73. Aenova Recent Developments
    Table 74. Sirio Pharma Company Details
    Table 75. Sirio Pharma Business Overview
    Table 76. Sirio Pharma Softgel CDMO Product
    Table 77. Sirio Pharma Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 78. Sirio Pharma Recent Developments
    Table 79. Procaps Company Details
    Table 80. Procaps Business Overview
    Table 81. Procaps Softgel CDMO Product
    Table 82. Procaps Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 83. Procaps Recent Developments
    Table 84. Patheon Company Details
    Table 85. Patheon Business Overview
    Table 86. Patheon Softgel CDMO Product
    Table 87. Patheon Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 88. Patheon Recent Developments
    Table 89. NextPharma Company Details
    Table 90. NextPharma Business Overview
    Table 91. NextPharma Softgel CDMO Product
    Table 92. NextPharma Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 93. NextPharma Recent Developments
    Table 94. Lonza Company Details
    Table 95. Lonza Business Overview
    Table 96. Lonza Softgel CDMO Product
    Table 97. Lonza Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 98. Lonza Recent Developments
    Table 99. Samsung Biologics Company Details
    Table 100. Samsung Biologics Business Overview
    Table 101. Samsung Biologics Softgel CDMO Product
    Table 102. Samsung Biologics Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 103. Samsung Biologics Recent Developments
    Table 104. Fareva Company Details
    Table 105. Fareva Business Overview
    Table 106. Fareva Softgel CDMO Product
    Table 107. Fareva Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 108. Fareva Recent Developments
    Table 109. WuXi AppTech Company Details
    Table 110. WuXi AppTech Business Overview
    Table 111. WuXi AppTech Softgel CDMO Product
    Table 112. WuXi AppTech Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 113. WuXi AppTech Recent Developments
    Table 114. WuXi Biologics Company Details
    Table 115. WuXi Biologics Business Overview
    Table 116. WuXi Biologics Softgel CDMO Product
    Table 117. WuXi Biologics Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 118. WuXi Biologics Recent Developments
    Table 119. Siegfried Company Details
    Table 120. Siegfried Business Overview
    Table 121. Siegfried Softgel CDMO Product
    Table 122. Siegfried Revenue in Softgel CDMO Business (2019-2024) & (US$ Million)
    Table 123. Siegfried Recent Developments
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Softgel CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Softgel CDMO Market Share by Type: 2023 VS 2030
    Figure 3. Pharmaceutical Softgel CDMO Features
    Figure 4. Nutraceutical Softgel CDMO Features
    Figure 5. Others Features
    Figure 6. Global Softgel CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Softgel CDMO Market Share by Application: 2023 VS 2030
    Figure 8. Pharmaceutical Company Case Studies
    Figure 9. Biotechnology Company Case Studies
    Figure 10. Others Case Studies
    Figure 11. Softgel CDMO Report Years Considered
    Figure 12. Global Softgel CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Softgel CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Softgel CDMO Market Share by Region: 2023 VS 2030
    Figure 15. Global Softgel CDMO Market Share by Players in 2023
    Figure 16. Global Top Softgel CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Softgel CDMO as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Softgel CDMO Revenue in 2023
    Figure 18. North America Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Softgel CDMO Market Share by Type (2019-2030)
    Figure 20. North America Softgel CDMO Market Share by Application (2019-2030)
    Figure 21. North America Softgel CDMO Market Share by Country (2019-2030)
    Figure 22. United States Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Softgel CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Softgel CDMO Market Share by Type (2019-2030)
    Figure 26. Europe Softgel CDMO Market Share by Application (2019-2030)
    Figure 27. Europe Softgel CDMO Market Share by Country (2019-2030)
    Figure 28. Germany Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Softgel CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Softgel CDMO Market Share by Type (2019-2030)
    Figure 36. China Softgel CDMO Market Share by Application (2019-2030)
    Figure 37. Asia Softgel CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Softgel CDMO Market Share by Type (2019-2030)
    Figure 39. Asia Softgel CDMO Market Share by Application (2019-2030)
    Figure 40. Asia Softgel CDMO Market Share by Region (2019-2030)
    Figure 41. Japan Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Softgel CDMO Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Softgel CDMO Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Softgel CDMO Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Softgel CDMO Market Share by Country (2019-2030)
    Figure 51. Brazil Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Softgel CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Catalent Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 58. Aenova Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 59. Sirio Pharma Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 60. Procaps Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 61. Patheon Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 62. NextPharma Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 63. Lonza Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 64. Samsung Biologics Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 65. Fareva Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 66. WuXi AppTech Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 67. WuXi Biologics Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 68. Siegfried Revenue Growth Rate in Softgel CDMO Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed